Skip to main content
SpringerLink
Log in

Emery-Dreifuss-Muskeldystrophie

Klinische Variabilität und genetische Heterogenität

Emery-Dreifuss muscular dystrophy

Clinical variability and genetic heterogeneity

  • Schwerpunkt
  • Published:
medizinische genetik

Zusammenfassung

Die Emery-Dreifuss-Muskeldystrophie (EDMD) ist eine seltene neuromuskuläre Erkrankung, die durch frühe Kontrakturen, eine langsam progrediente Muskelschwäche und lebensbedrohliche Herzrhythmusstörungen gekennzeichnet ist. Sowohl klinisch als auch genetisch findet man eine große intra- und interfamiliäre Variabilität. Genetisch lassen sich X-chromosomal rezessive (EMD1), autosomal-dominante (EMD2) und autosomal-rezessive (EMD3) Formen unterscheiden, die mit Mutationen in den Genen STA, LMNA, SYNE1, SYNE2 und FHL1 assoziiert sind. Nur bei etwa 46% nicht miteinander verwandter EDMD-Patienten findet man Mutationen in diesen Genen, sodass mit einer weiteren genetischen Heterogenität der EDMD zu rechnen ist.

Abstract

Emery-Dreifuss muscular dystrophy (EDMD) is a rare neuromuscular disorder characterized by early contractures, slowly progressive muscular weakness, and life-threatening heart conduction disturbances that can develop into a cardiomyopathy. There is wide intrafamilial and interfamilial clinical variability. Genetically, X-linked recessive (EMD1), autosomal dominant (EMD2), and autosomal recessive (EMD3) forms can be distinguished, which are associated with mutations in the STA, LMNA, SYNE1, SYNE2, and FHL1 genes. Only approximately 46% of unrelated EDMD patients have a mutation in the genes mentioned above, pointing to further genetic heterogeneity in EDMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Ben Yaou R, Toutain A, Arimura T et al (2007) Multitissular involvement in a family with LMNA and EMD mutations: role of digenic mechanism? Neurology 68:1883–1894

    Article  Google Scholar 

  2. Bione S, Maestrini E, Rivella S et al (1994) Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8:323–327

    Article  PubMed  CAS  Google Scholar 

  3. Bonne G, Di Barletta MR, Varnous S et al (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285–288

    Article  PubMed  CAS  Google Scholar 

  4. Bonne G, Mercuri E, Muchir A et al (2000) Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 2:170–180

    Article  Google Scholar 

  5. Boyle S, Gilchrist S, Bridger, JM et al (2001) The spatial organization of human chromosomes within the nuclei of normal and emerin-mutant cells. Hum Mol Genet 10:211–219

    Article  PubMed  CAS  Google Scholar 

  6. Cestan R, Lejonne NI (1902) Une myopathie avec retractions familiales. Nouv Inconogr Salpetriere 15:38–52

    Google Scholar 

  7. Di Barletta R, Ricci M, Galluzzi E et al (2000) Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 66:1407–1412

    Article  Google Scholar 

  8. Emery AEH (1989) Emery-Dreifuss syndrome. J Med Genet 26:637–641

    Article  PubMed  CAS  Google Scholar 

  9. Gruenbaum Y, Wilson KL, Harel A et al (2000) Review: nuclear lamins – structural proteins with fundamental functions. J Struct Biol 129:313–323

    Article  PubMed  CAS  Google Scholar 

  10. Gueneau L, Bertrand A, Jais JP et al (2008) A new X-linked form of Emery-Dreifuss muscular dystrophy is caused by FHL1 gene mutations that lead to abnormal muscle differentiation. 13th International WMS Congress, 29th September–2nd October, Newcastle, UK

  11. Hauptmann A, Tannhauser SJ (1941) Muscular shortening and dystrophy. Arch Neurol 46:654–666

    Google Scholar 

  12. Wehnert M, Muntoni F (1999) 60th ENMC International workshop: Non-X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 9:115–121

    Article  PubMed  CAS  Google Scholar 

  13. Windpassinger C, Schoser B, Straub V et al (2007) A novel X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82:88–99

    Article  Google Scholar 

  14. Worman HJ, Bonne G (2007) Laminopathies: a wide spectrum of human disease. Exp Cell Res 313:2121–2133

    Article  PubMed  CAS  Google Scholar 

  15. Zhang Q, Bethmann C, Worth NF et al (2007) Nesprin-1 and -2 are involved in the pathogenesis of Emery-Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet 16:2816–2833

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Institut für Humangenetik, Fleischmannstraße 42/44, 17487, Greifswald, Deutschland

    M. Wehnert

Authors
  1. M. Wehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Wehnert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wehnert, M. Emery-Dreifuss-Muskeldystrophie. medgen 21, 343–348 (2009). https://doi.org/10.1007/s11825-009-0173-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11825-009-0173-8

Schlüsselwörter

Keywords

Search

Navigation